[QALY conceals unacceptable values: Use relevant effects to determine drug benefit]
Lakartidningen
.
2016 Apr 11:113:DYZ3.
[Article in Swedish]
Authors
Peter Höglund
,
Göran Hermerén
,
Nils-Eric Sahlin
PMID:
27070394
No abstract available
Publication types
Letter
MeSH terms
Cost-Benefit Analysis / methods*
Humans
Quality-Adjusted Life Years*